As hypothesized, the analysis of subjects with SMA revealed a significant difference for SMN2-FL (and hence, Total SMN-FL) transcript levels for Type I vs Type II, Type I vs Type III and Type II vs Type III (p = 0.031, <0.001, 0.024, respectively). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.